Lithium and gene expression: implications to Alzheimer disease.

Author(s)

Camila Teixeira Mendes

• Document type: Doctoral Thesis
• Press: São Paulo.
• Institution: Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB/SDI)
• Defense date: 2008-03-14

Examining board members

Emmanuel Dias Neto; Anamaria Aranha Camargo; Lygia da Veiga Pereira Carramaschi; Luciana Amaral Haddad; Eloisa de Sá Moreira

• Advisor: Emmanuel Dias Neto

Abstract

The increased systemic expression of active GSK3b in Alzheimers disease (AD) patients apparently is associated with the formation of senile plaques and neurofibrillary tangles, the hallmarks of this disease. In this study we used qPCR to evaluate the transcriptional regulation of GSK3a and GSK3b in lithium-treated primary cultures of rat cortical and hippocampal neurons. We found a significant and dose-dependent reduction in the mRNA levels of GSK3b, which was specific to hippocampus. This same effect was further confirmed in vivo by measuring GSK3 expression in different brain regions of adult rats treated with lithium. We used subtractive hybridizations and two-dimensional electrophoresis patterns of culture of hippocampus neurons treated with lithium. Our study suggested 88 genes differently expressed besides 8 proteins identified with variation expression. These observations suggest new regulatory effects of lithium over GSK3b and suggesting new potential lithium action targets. (AU)

• FAPESP's process: 04/01478-2 - Molecular analysis of genes related to the central nervous system neurodegeneration in Alzheimer's Disease
• Grantee: Camila Teixeira Mendes
• Support Opportunities: Scholarships in Brazil - Doctorate